tweetindex
EN

Urology Times ✓

@UrologyTimes · Cranbury, NJ · joined 21 Mar 2012

The Leading News Source for Urologists - https://t.co/hDKngB4IyE Expert clinical analysis. Practice advice. Policy perspectives.

24 617Followers
2 082Following
32 391Posts total
3.5KViews on collected posts

Latest posts

The @FDA has granted Regenerative Medicine Advanced Therapy designation to EG110A, which is under development for neurogenic detrusor overactivity with urinary incontinence. https://t.co/cMybPqMAb4 539 views · 0 likes · 0 reposts · 1 replies Open on X →
WATCH: Sasha Vereecken, BScN, RN, (@sjvereeck) discusses how patient unawareness rivals diagnostic gaps as a barrier in functional urology. @CU_Urology https://t.co/9Q1RzlSudF 628 views · 1 likes · 1 reposts · 0 replies Open on X →
The @FDA has granted clearance to the LigaSure RAS Maryland jaw device for use with Medtronic’s Hugo robotic-assisted surgery system. https://t.co/BbEZx4DFQe 781 views · 0 likes · 0 reposts · 0 replies Open on X →
In the latest episode of The #UroOncMinute, Surena Matin, MD, (@SurenaMatinMD) joins host Adam Weiner, MD, (@Adam_Weiner535) to discuss the use of intraoperative chemotherapy at the time of nephroureterectomy. #UTUC Watch the full episode: https://t.co/zA0PBFZKvY https://t.co/e
1:08
729 views · 0 likes · 0 reposts · 0 replies Open on X →
WATCH: Andrew Peterson, MD, discusses the quality of life impact of post-cancer incontinence and advances in artificial urinary sphincter technology. @DukeHealth https://t.co/oOfCCIskKa 835 views · 1 likes · 0 reposts · 1 replies Open on X →

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views729this account924median for 10K–100K
Reach, %2.96%this account3.62%median for 10K–100K
Engagement, %0.19%this account1.52%median for 10K–100K
MetricThis accountMedian for 10K–100KRatio
Median views per post7299240.79×
Reach (views ÷ followers)2.96%3.62%0.82×
Engagement rate0.19%1.52%0.12×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

83515 Sep
72916 Sep
781
62817 Sep
539

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.24%15 Sep
0.00%16 Sep
0.00%
0.32%17 Sep
0.19%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes40.0%2 in total
Reposts20.0%1 in total
Replies40.0%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Similar accounts